Skip to main content

RDY 355 (Rivastigmine Tartrate 6 mg)

Pill with imprint RDY 355 is Brown & Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Dr. Reddy's Laboratories Ltd.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 355

Rivastigmine tartrate 6 mg RDY 355
Rivastigmine tartrate 6 mg RDY 355
Rivastigmine tartrate 6 mg RDY 355
Rivastigmine tartrate 6 mg RDY 355

Rivastigmine Tartrate

Imprint
RDY 355
Strength
6 mg
Color
Brown & Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
55111-0355
Inactive Ingredients
silicon dioxide, hypromellose 2910 (5 mPa.s), magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.